3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings are the only transparent dressings proven to reduce CRBSI.
In a randomized control trial, Tegaderm CHG I.V. Securement Dressings had a 60% reduction of CRBSIs1. Plus, Tegaderm CHG I.V. Securement Dressings have 100% correct application of the CHG2 compared to BioPatch® Disks with CHG.
Want to learn more? Download the comparison flier to see how Tegaderm CHG I.V. Securement Dressings compare to BioPatch® Disks with CHG in multiple design and performance categories.
1. Timsit JF, et al. Randomized Controlled Trial of Chlorhexidine Dressing and Highly Adhesive Dressing for Preventing Catheter-Related Infections in critically ill adults. American Journal of Respiratory and Critical Care Medicine 2012; 186 (12):1272-1278.
2. Kohan C., MT, MS, CIC, Boyce J., MD. American Journal of Infection Control (AJIC); 2013; Vol 41, Issue 6, S142–S143; doi http://dx.doi.org/10.1016/j.ajic.2013.03.283.
Important Safety Information for 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings and 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad. Do not use Tegaderm™ CHG I.V. Securement Dressings or Tegaderm™ CHG Gel Pad on premature infants or infants younger than two months of age. Use of these products on premature infants may result in hypersensitivity reactions or necrosis of the skin. The safety and effectiveness of Tegaderm™ CHG I.V. Securement Dressings and Tegaderm™ CHG Gel Pad has not been established in children under 18 years of age. For full prescribing information, see the Instructions for Use (IFU). Rx Only.
The brands listed above are trademarks of 3M.